Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$0.69 - $1.21 $27 - $48
40 Added 0.05%
80,924 $78,000
Q1 2022

May 16, 2022

SELL
$1.02 - $3.8 $20,808 - $77,520
-20,400 Reduced 20.14%
80,884 $96,000
Q4 2021

Feb 14, 2022

BUY
$3.26 - $4.66 $170,172 - $243,252
52,200 Added 106.35%
101,284 $330,000
Q3 2021

Nov 15, 2021

BUY
$4.08 - $5.66 $200,262 - $277,815
49,084 New
49,084 $219,000
Q1 2021

May 17, 2021

SELL
$7.19 - $14.95 $342,193 - $711,515
-47,593 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$6.66 - $14.66 $316,969 - $697,713
47,593 New
47,593 $516,000

About Syros Pharmaceuticals, Inc.


  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $4.05M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.